Efficacy of endoscopic retrograde cholangiopancreatography combined with electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system in treatment of difficult choledocholithiasis

Liying TAO; Hongguang WANG; Qingmei GUO; Lianyu PIAO; Xiang GUO; Libin RUAN; Shizhu LIU; Zhen SUN

doi:10.12449/JCH240220

Volume 40 Issue 2

Feb. 2024

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(2): 351-355

PDF( 807 KB)

Efficacy of endoscopic retrograde cholangiopancreatography combined with electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system in treatment of difficult choledocholithiasis

DOI: 10.12449/JCH240220

Department of Gastroenterology，Jilin People’s Hospital，Jilin，Jilin 132001，China

Research funding:

Jilin Province Health Science and Technology Capacity Improvement Project (2022LC143)

More Information

Corresponding author: WANG Hongguang， wanghongguang1817@163.com （ORCID： 0000-0003-1100-9804）
Received Date: 2023-05-19
Accepted Date: 2023-06-20
Published Date: 2024-02-19

Abstract

Abstract

Objective To investigate the safety and efficacy of endoscopic retrograde cholangiopancreatography （ERCP） combined with electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system in the treatment of difficult choledocholithiasis. Methods A retrospective analysis was performed for the clinical data of 12 patients with difficult choledocholithiasis who underwent ERCP and electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system in Department of Gastroenterology， Jilin People’s Hospital， from May to November 2022. The clinical effect of lithotripsy and lithotomy was observed， and postoperative complications and time of surgical operation were assessed. Results Among the 12 patients， 11 （91.67%） were successfully treated by electrohydraulic lithotripsy under direct view， 9 （75.00%） achieved first-attempt success in lithotripsy， and 11 （91.67%） had complete removal of calculi； 1 patient was found to have stenosis of the bile ducts caused by multiple biliary tract surgeries， and grade Ⅱ intrahepatic bile duct stones above the sites of stenosis were removed under direct view， but there were still residues of grade Ⅲ intrahepatic bile duct stones， which led to the fact that complete calculus removal was not achieved. The mean time of ERCP operation was 91.3±26.2 minutes， including a time of 41.8±22.2 minutes for energy lithotripsy. There were 2 cases of postoperative biliary tract infection which were improved after anti-infective therapy， 2 cases of hyperamylasemia which were not given special treatment， and 3 cases of mild pancreatitis which were improved after symptomatic medication， and there were no complications such as bleeding and perforation. Conclusion ERCP combined with electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system is safe， effective， and feasible in the treatment of difficult choledocholithiasis.
- Choledocholithiasis,
- Cholangiopancreatography， Endoscopic Retrograde,
- eyeMax Bilio-Pancreatic Imaging System,
- Lithotripsy

FullText(HTML)

References(18)

References

[1]	NAKAI Y, SATO T, HAKUTA R, et al. Management of difficult bile duct stones by large balloon, cholangioscopy, enteroscopy and endosonography[J]. Gut Liver, 2020, 14( 3): 297- 305. DOI: 10.5009/gnl19157.
[2]	FENG YP, GAO Y, XIN L, et al. Advances in endoscopic therapy for difficult common bile duct stones[J]. J Clin Hepatol, 2021, 37( 1): 229- 232. DOI: 10.3969/j.issn.1001-5256.2021.01.051. 冯拥璞, 高野, 辛磊, 等. 困难胆总管结石的内镜治疗进展[J]. 临床肝胆病杂志, 2021, 37( 1): 229- 232. DOI: 10.3969/j.issn.1001-5256.2021.01.051.
[3]	KAMIYAMA R, OGURA T, OKUDA A, et al. Electrohydraulic lithotripsy for difficult bile duct stones under endoscopic retrograde cholangiopancreatography and peroral transluminal cholangioscopy guidance[J]. Gut Liver, 2018, 12( 4): 457- 462. DOI: 10.5009/gnl17352.
[4]	TRONCONE E, MOSSA M, DE VICO P, et al. Difficult biliary stones: A comprehensive review of new and old lithotripsy techniques[J]. Medicina, 2022, 58( 1): 120. DOI: 10.3390/medicina58010120.
[5]	LIU YJ, WU Q. Efficacy and safety of SpyGlass system combined with electrohydraulic lithotripsy during endoscopic retrograde cholangiopancreatography in treatment of difficult common bile duct stones[J]. J Clin Hepatol, 2021, 37( 7): 1644- 1647. DOI: 10.3969/j.issn.1001-5256.2021.07.032. 刘益均, 吴乔. 内镜逆行胰胆管造影术中使用SpyGlass系统联合液电碎石治疗胆总管困难结石的效果及安全性分析[J]. 临床肝胆病杂志, 2021, 37( 7): 1644- 1647. DOI: 10.3969/j.issn.1001-5256.2021.07.032.
[6]	BOKEMEYER A, GERGES C, LANG DA, et al. Digital single-operator video cholangioscopy in treating refractory biliary stones: A multicenter observational study[J]. Surg Endosc, 2020, 34( 5): 1914- 1922. DOI: 10.1007/s00464-019-06962-0.
[7]	DONG H, ZHANG WG, LIU SZ, et al. Preliminary study of extraction for common bile duct stones under cholangioscopy[J/CD]. Chin J Gastrointestial Endoscopy(Electronic Editon), 2023, 10( 2): 92- 96. DOI: 10.3877/cma.j.issn.2095-7157.2023.02.003. 董浩, 张文刚, 刘圣圳, 等. 胆道镜直视下胆总管结石取出术的初步探索[J/CD]. 中华胃肠内镜电子杂志, 2023, 10( 2): 92- 96. DOI: 10.3877/cma.j.issn.2095-7157.2023.02.003.
[8]	ZHANG TX, LYU YF, ZHENG JF. Progress of minimally invasive treatments for choledocholithiasis[J/OL]. Chin J Hepat Surg(Electronic Edition), 2023, 12( 5): 585- 588. DOI: 10.3877/cma.j.issn.2095-3232.2023.05.022. 张天献, 吕云福, 郑进方. 胆总管结石微创治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12( 5): 585- 588. DOI: 10.3877/cma.j.issn.2095-3232.2023.05.022.
[9]	LI GD, PANG QP, ZHAI HL, et al. SpyGlass-guided laser lithotripsy versus laparoscopic common bile duct exploration for large common bile duct stones: A non-inferiority trial[J]. Surg Endosc, 2021, 35( 7): 3723- 3731. DOI: 10.1007/s00464-020-07862-4.
[10]	BANG JY, SUTTON B, NAVANEETHAN U, et al. Efficacy of single-operator cholangioscopy-guided lithotripsy compared with large balloon sphincteroplasty in management of difficult bile duct stones in a randomized trial[J]. Clin Gastroenterol Hepatol, 2020, 18( 10): 2349- 2356. DOI: 10.1016/j.cgh.2020.02.003.
[11]	YAN S, TEJASWI S. Clinical impact of digital cholangioscopy in management of indeterminate biliary strictures and complex biliary stones: A single-center study[J]. Ther Adv Gastrointest Endosc, 2019, 12: 2631774519853160. DOI: 10.1177/2631774519853160.
[12]	WANG YC, JIN HB, HUANG HT, et al. The diagnostic and therapeutic value of SpyGlass direct visualization system for cholangiopancreatic duct stenosis and large bile duct stones[J]. Chin J Dig Endosc, 2020, 37( 9): 632- 637. DOI: 10.3760/cma.j.cn321463-20191124-00784. 王雨承, 金杭斌, 黄海涛, 等. SpyGlass内镜直视系统在胆胰管狭窄及胆管巨大结石中的诊治作用[J]. 中华消化内镜杂志, 2020, 37( 9): 632- 637. DOI: 10.3760/cma.j.cn321463-20191124-00784.
[13]	MANES G, PASPATIS G, AABAKKEN L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy(ESGE) guideline[J]. Endoscopy, 2019, 51( 5): 472- 491. DOI: 10.1055/a-0862-0346.
[14]	SHI JL, CHENG SL, JIN HB, et al. ERCP combined with SpyGlass DS direct visualization electrohydraulic lithotripsy in treatment of difficult bile duct stones[J]. J Surg Concepts Pract, 2022, 27( 2): 165- 168. DOI: 10.16139/j.1007-9610.2022.02.015. 石加利, 程思乐, 金杭斌, 等. ERCP联合SpyGlass DS直视下液电碎石治疗困难胆总管结石[J]. 外科理论与实践, 2022, 27( 2): 165- 168. DOI: 10.16139/j.1007-9610.2022.02.015.
[15]	MCCARTY TR, GULATI R, RUSTAGI T. Efficacy and safety of peroral cholangioscopy with intraductal lithotripsy for difficult biliary stones: A systematic review and meta-analysis[J]. Endoscopy, 2021, 53( 2): 110- 122. DOI: 10.1055/a-1200-8064.
[16]	CHO YD, CHEON YK, MOON JH, et al. Clinical role of frequency-doubled double-pulsed yttrium aluminum garnet laser technology for removing difficult bile duct stones(with videos)[J]. Gastrointest Endosc, 2009, 70( 4): 684- 689. DOI: 10.1016/j.gie.2009.03.1170.
[17]	TUROWSKI F, HÜGLE U, DORMANN A, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: Results of a multicenter retrospective cohort study[J]. Surg Endosc, 2018, 32( 9): 3981- 3988. DOI: 10.1007/s00464-018-6141-0.
[18]	MAYDEO AP, RERKNIMITR R, LAU JY, et al. Cholangioscopy-guided lithotripsy for difficult bile duct stone clearance in a single session of ERCP: Results from a large multinational registry demonstrate high success rates[J]. Endoscopy, 2019, 51( 10): 922- 929. DOI: 10.1055/a-0942-9336.

Relative Articles

[1]	Hepatobiliary Study Group of Chinese Society of Gastroenterology of Chinese Medical Association, Hepatology Committee of Chinese Research Hospital Association. Practice guidance for the use of terlipressin for liver cirrhosis related complications (2021)[J]. Journal of Clinical Hepatology, 2022, 38(8): 1733-1738. doi: 10.3969/j.issn.1001-5256.2022.08.006
[2]	Qianmei CAO, Zhechuan MEI. Predictive factors for the therapeutic effect of terlipressin combined with albumin in hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2021, 37(10): 2439-2443. doi: 10.3969/j.issn.1001-5256.2021.10.038
[3]	LIAO XianHua, YE JunZhao, ZHONG BiHui. Pathogenesis of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2020, 36(11): 2406-2410. doi: 10.3969/j.issn.1001-5256.2020.11.002
[4]	Li XiaoLu, Ding HuiGuo, Ceng AJuan, Lu: XinYue, Li Lei. Clinical effect of terlipressin combined with somatostatin in treatment of esophagogastric variceal bleeding with liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(6): 1273-1277. doi: 10.3969/j.issn.1001-5256.2020.06.017
[5]	Li XiaoLu, Li Lei. Application of terlipressin in the treatment of esophagogastric variceal bleeding in liver cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2308-2311. doi: 10.3969/j.issn.1001-5256.2019.10.038
[6]	Tan YanXin, Long FuLi, Mao DeWen, Zhang JianLing, Ma YuZhen, Yan LianJie. Efficacy and safety of norepinephrine combined with albumin versus terlipressin combined with albumin in treatment of type 1 hepatorenal syndrome:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2266-2271. doi: 10.3969/j.issn.1001-5256.2019.10.027
[7]	Feng QingLing, Feng ZeMin, Zhang ChunQing, Wang GuangChuan, Feng Hua. Effects of terlipressin and double- dose octreotide on hepatic venous pressure gradient in patients with liver cirrhosis:a comparative study[J]. Journal of Clinical Hepatology, 2016, 32(4): 720-723. doi: 10.3969/j.issn.1001-5256.2016.04.022
[8]	Xia YuLian, Zhang ChunQing, Wang GuangChuan, Feng Hua, Zhang MingYan. Individual and combined effects of octreotide and terlipressin on hepatic venous pressure gradient in cirrhotic patients[J]. Journal of Clinical Hepatology, 2015, 31(2): 214-218. doi: 10.3969/j.issn.1001-5256.2015.02.017
[9]	Ding XiaoHong, Gu JianYing. Clinical efficacy of terlipressin in treatment of type II hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2015, 31(5): 745-748. doi: 10.3969/j.issn.1001-5256.2015.05.027
[10]	Zhan GuoQing, Li Fang, Li RuGui, Guo Peng, Liu Xiang, Zhang WeiWei, Tan HuaBing. Efficacy of terlipressin therapy for refractory ascites in cirrhosis and type-2 hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2015, 31(8): 1287-1290. doi: 10.3969/j.issn.1001-5256.2015.08.025
[11]	Gao BaoXiu, Nie Xin, He Yong, Yang ZhengBing, Luo TongXing, Song HaoLan, Li GuiXing. Analysis of endotoxin and endothelin-1 levels in patients with type 1 hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2014, 30(1): 58-61. doi: 10.3969/j.issn.1001-5256.2014.01.016
[12]	Chen Si, Sun ZhangYu, Zhang ZhiHao, Wang YingYing. Therapeutic effect of terlipressin combined with albumin in 24 patients with hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2014, 30(8): 782-784. doi: 10.3969/j.issn.1001-5256.2014.08.021
[13]	Zheng XiaoLi, Wang LiangZhi, He JianHua, Xiang XingChao, Zhou XiangYu. Diagnostic value of serum cystatin C and urotensin II for hepatorenal syndrome in patients with decompensated liver cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(8): 627-630. doi: 10.3969/j.issn.1001-5256.2013.08.019
[14]	Gao BaoXiu, Nie Xin, Wu Bin, He Yong, Song HaoLan, Luo TongXing, Xu Jing, Li GuiXing. Implications of elevated levels of prostaglandin I2 and thromboxane A2 in type I hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2012, 28(11): 860-862.
[15]	Wang JiYao. The difficulties in diagnosis and treatment of hepatorenal syndrome-raised by clinical cases[J]. Journal of Clinical Hepatology, 2011, 27(10): 1019-1021.
[16]	Xu XiaoYuan, Zheng YingYing. Hepatorenal syndrome-vasoconstrictor or vasodilator?[J]. Journal of Clinical Hepatology, 2011, 27(8): 801-803+817.
[17]	Xie YongPeng, Hou Yue, Zang XiuXian, Chu Zhe. The development of treatment of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2011, 27(5): 558-561.
[18]	Zheng XiaoLi, Wang LiangZhi. Current diagnosis and treatment of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2011, 27(1): 107-109.
[19]	Fu Qiang, Tang TongYu. Advance in research of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2010, 26(5): 557-560.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (528) PDF downloads(83)

Efficacy of endoscopic retrograde cholangiopancreatography combined with electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system in treatment of difficult choledocholithiasis

DOI: 10.12449/JCH240220

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Efficacy of endoscopic retrograde cholangiopancreatography combined with electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system in treatment of difficult choledocholithiasis

DOI: 10.12449/JCH240220

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content